Charles River Laboratories | GJELD



Debt Endring Dato
Agilent USD 3.36B 27M 2025-01
Align Technology USD 0 0 2024-12
Bio-Rad Laboratories USD 1.2B 300K 2025-03
Bruker USD 2.09B 203M 2024-12
Cardinal Health USD 7.68B 73M 2025-03
Charles River Laboratories USD 2.24B 86.72M 2024-12
Cigna USD 30.45B 1.52B 2025-03
CVS Health USD 64.71B 1.56B 2025-03
Danaher USD 16.48B 472M 2025-03
Dentsply International USD 2.14B 82M 2024-12
Elevance Health USD 30B 1.23B 2025-03
Galapagos EUR 10.86M 864K 2025-03
Hologic USD 2.53B 9.4M 2025-03
Humana USD 13.88B 2.16B 2025-03
Illumina USD 1.99B 1000K 2024-12
Incyte USD 37.12M 840K 2025-03
IQVIA Holdings USD 14.33B 347M 2025-03
Laboratory Of America USD 6.52B 107.7M 2025-03
Lonza CHF 4.71B 915M 2024-12
McKesson USD 8.01B 2.27B 2024-12
Merck EUR 10.27B 1.11B 2024-12
Mettler Toledo International USD 2.07B 60.21M 2025-03
Novartis USD 31.26B 828M 2024-12
Pfizer USD 62.11B 2.24B 2025-03
Quest Diagnostics USD 5.86B 358M 2025-03
Revvity USD 3.17B 17.91M 2025-03
Thermo Fisher Scientific USD 34.19B 2.91B 2025-03
United Therapeutics USD 200M 100M 2025-03
UnitedHealth USD 81.27B 4.37B 2025-03
Walgreens Boots Alliance USD 8.02B 1.04B 2025-02
Waters USD 1.46B 169.76M 2025-03
West Pharmaceutical Services USD 202.6M 3M 2025-03



Charles River Laboratories GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.